Bath & Body Works (BBWI) EBITDA Margin (2009 - 2026)

Bath & Body Works has disclosed EBITDA Margin across 18 years of filings, most recently posting 21.99% for Q1 2026.

• In Q1 2026, EBITDA Margin fell 234.0% year-over-year to 21.99%; the TTM figure through Jan 2026 stood at 15.44% (down 188.0% YoY), while the FY2026 annual figure was 15.44%, down 188.0% from the prior year.
• EBITDA Margin advanced to 21.99% in Q1 2026, from 10.1% in the prior quarter.
• Over the last five years, EBITDA Margin for BBWI reached as high as 29.04% in Q1 2022 and fell as low as 10.1% in Q4 2025.
• The 5-year median for EBITDA Margin is 14.15% (2023), against an average of 16.58%.
• Annual changes were most pronounced in 2022 — EBITDA Margin plunged 1174 bps — and 2023, when it surged 156 bps.
• A 5-year view of EBITDA Margin shows it stood at 12.59% in 2022, then increased by 12 bps to 14.15% in 2023, then retreated by 4 bps to 13.54% in 2024, then slipped by 25 bps to 10.1% in 2025, then soared by 118 bps to 21.99% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 21.99%, 10.1%, and 10.14% for Q1 2026, Q4 2025, and Q3 2025 respectively.